Ionis and Ultragenyx are competing to develop oligonucleotide treatments for Angelman syndrome, but will Neuren’s peptide ...

The first peer-reviewed scientific paper examining Rumin8’s investigational veterinary product has confirmed its ...

Tris Pharma’s first-in-class oral dual-NMR agonist achieved its primary endpoint in the ALLEVIATE-2 study by demonstrating a ...

This trial will evaluate the feasibility of the company’s investigational AeroNova ® System in patients suffering from moderate to severe Acute Hypoxemic Respiratory Failure (AHRF). The ...

Lungpacer Medical, a leading neurostimulation company committed to advancing therapies that assist patients in overcoming the ...

Investigational Long-Acting, Twice-Yearly Treatment Regimen of Lenacapavir and Broadly Neutralizing Antibodies (bNAbs) Meets Primary Endpoint in Phase 2 Study and Gains Breakthrough Therapy ...